Log in to save to my catalogue

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2394437

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

About this item

Full title

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

Publisher

Basingstoke: Nature Publishing Group

Journal title

British journal of cancer, 2003-11, Vol.89 (10), p.1817-1821

Language

English

Formats

Publication information

Publisher

Basingstoke: Nature Publishing Group

More information

Scope and Contents

Contents

Matrix metalloproteinases (MMPs) were initially recognised for their extracellular matrix (ECM)-degrading capability during tissue remodelling. Their importance was further highlighted by their role in metastasis. Clinical trials have since evaluated the potential of MMP inhibitors as anticancer therapeutics, but without success. These initial stud...

Alternative Titles

Full title

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2394437

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2394437

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/sj.bjc.6601327

How to access this item